Skip to content
Screener

Core Scientific, Inc. CORZ Preferred Stock, Shares Authorized

Preferred Stock, Shares Authorized at other companies

TeraWulf logo
TeraWulfWULF
$100M0.0%
Marathon Digital Holdings logo
Marathon Digital HoldingsMARA
$50M0.0%
Cipher Digital, Inc. logo
Cipher Digital, Inc.CIFR
DTC
Datacentrex, Inc.DTCX

Other financials

Income statement

See full
Revenue$164.2M+109%
Gross profit$70.0M+1,294%
Operating income-$78.5M-199%
Net income-$1.2B-23.3%
EPS (diluted)-$3.32-8,200%

Balance sheet

See full
Cash & equivalents$2.6B+339%
Total debt$4.4B+279%
Total equity-$2.4B-127%
Total assets$5.3B+166%

Cash flow

See full
Operating cash flow$249.9M+715%
CapEx$565.0M+366%
Free cash flow-$583.9M-569%

Valuation

See full
Market cap$6.25B+40.8%
Enterprise value$8.1B+61.5%
P/S14.2×+1.5×

Profitability

See full
Gross margin28.3%+23.2pp
Operating margin-128.5%-362pp
Net margin-237.6%-3.1pp
FCF margin-217.5%-446pp

Returns & leverage

See full
Return on equity148.5%
Debt / equity2.2×
Current ratio0.9×-0.9×

Where this comes from

Reported directly by Core Scientific, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.

The source filing: Core Scientific, Inc.’s 10-Q, filed July 28, 2026.

Filed
Jul 28, 2026, 7:08 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001839341-26-000014
Line itemJune 30,2026December 31,2025
Total Liabilities7,676,8493,310,384
Commitments and contingencies (Note 10)
Stockholders’ Deficit:
Preferred stock; $0.00001 par value; 2,000,000 shares authorized; none issued and outstanding at June 30, 2026 and December 31, 2025
Common stock; $0.00001 par value; 10,000,000 shares authorized at June 30, 2026 and December 31, 2025; 319,587 and 314,231 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively33
Additional paid-in capital3,229,8423,183,960
Accumulated deficit(5,649,201)(4,146,703)
Total Stockholders’ Deficit(2,419,356)(962,740)

Item 1. Financial Statements (Unaudited)

FAQ

What is Core Scientific, Inc.'s preferred stock, shares authorized?
Core Scientific, Inc. (CORZ) reported preferred stock, shares authorized of $2B in Q2 2026.
How has Core Scientific, Inc.'s preferred stock, shares authorized changed year-over-year?
Core Scientific, Inc.'s preferred stock, shares authorized decreased by 0.0% year-over-year, from $2B to $2B.
What is the long-term trend for Core Scientific, Inc.'s preferred stock, shares authorized?
Over 3 years (2020 to 2025), Core Scientific, Inc.'s preferred stock, shares authorized has grown at a 1159.9% compound annual growth rate (CAGR), from $1M to $2B.

Ask your AI about Core Scientific, Inc.'s preferred stock, shares authorized.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude